Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

ClearRead CT Adoption Continues to Accelerate

Riverain Technologies
Posted on: 14 Nov 17

Riverain Technologies’ ClearRead CT, recognized as a semi-finalist in the “Best New Software in Radiology” category for the Minnie awards, continues to accelerate adoption sequentially, quarter after quarter since FDA approval in September, 2016. Riverain’s ClearRead CT install base has expanded in the U.S. as leading institutions see the value in its efficient and effective detection of lung nodules across all chest CTs, including lung cancer screening exams. Purchases by the University of Michigan Medical Center, Saint Luke’s Kansas City and Naugatuck Valley Radiology Associates add to an already impressive list such as Duke University and Einstein Medical Center along with leading sites across Europe and Japan.

Naugatuck Valley Radiology Associates has adopted ClearRead CT across three facilities to improve patient care in their community. The adoption was based on a demonstrated strong value proposition around reading efficiency and improved nodule detection performance as part of a prospective trial.

“Naugatuck Valley Radiology Associates prides itself on being a leader and ensuring our community has access to affordable high quality imaging utilizing the best possible technology. We use the ClearRead CT software across our outpatient imaging network in central Connecticut, including those performing lung cancer screening,” said Paul Masotto, Executive Director at Naugatuck Valley Radiology Associates. “ClearRead CT was easily installed and integrated into our daily workflow. We are seeing immediate value.”

ClearRead CT is the first advanced visualization product cleared by the FDA for concurrent reading, enabling radiologists to read the original series and the processed CT series simultaneously. ClearRead CT is proven to achieve a 26% reduction in reading time and reduce missed nodules by 29%. The technology processes CT scans from all manufacturers and automatically places the processed series into the existing patient file. The seamless integration and ability to process cases from varying acquisition devices and protocols allows the ClearRead CT technology to be rapidly deployed enterprise wide, allowing a standard of care for the patient population within an enterprise health system.

“Riverain is excited to bring Naugatuck Valley Radiology Associates into the ClearRead CT family as we expand into radiology reading groups based on our strong value propositions around reading efficiency, reading accuracy and enterprise wide imaging,” said Steve Worrell, CEO of Riverain Technologies. “As CT data volume continues to increase, the ability to improve nodule detection accuracy while improving efficiency is increasingly important.”

ClearRead CT is proven to simultaneously improve both nodule detection accuracy and reading efficiency, solving a critical need at a critical time. ClearRead CT uses patented image normalization technology along with deep learning models to provide a robust clinical solution.

Riverain Technologies has established itself as a dedicated partner to thoracic radiologists and will be exhibiting at the Radiological Society of North America (RSNA) conference in Chicago, IL, November 26th – 30th. Visit booth #3710 or #8149P in the Machine Learning Showcase to learn more about the ClearRead CT technology.

Riverain Technologies

Riverain Technologies is a medical software innovator that develops solutions to aid radiologists in the early detection of disease. With the use of Riverain’s ClearRead Xray and ClearRead CT, radiologists are able to optimize the use of existing equipment. This enables radiologists to better utilize their diagnostic expertise in image interpretation for identification of diseases, such as lung cancer. For more information visit: http://www.riveraintech.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171114006103/en/

Business Wire
www.businesswire.com

Last updated on: 14/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.